Role of endothelin-1 in choroidal blood flow regulation during isometric exercise in healthy humans

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 2, 2003, Pages 728-733

  Fuchsjäger Mayrl, Gabriele ^a   Luksch, Alexandra ^a   Malec, Magdalena ^a   Polska, Elzbieta ^a   Wolzt, Michael ^a   Schmetterer, Leopold ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; PLACEBO;

ADULT; ARTICLE; AUTOREGULATION; BLOOD PRESSURE MEASUREMENT; CALCULATION; CHOROID VASCULARIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPPLER FLOWMETER; DOUBLE BLIND PROCEDURE; DRUG INFUSION; EYE BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR PRESSURE; ISOMETRIC EXERCISE; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; PROTEIN FUNCTION; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; VASOCONSTRICTION;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CHOROID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENALAPRIL; ENDOPEPTIDASES; ENDOTHELIN-1; EXERCISE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; PEPTIDES, CYCLIC; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN;

EID: 0037309979     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0372     Document Type: Article

References (47)

1. Kiel JW, Shepherd AP. Autoregulation of choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci. 1992;33:2399-2410.
2. Kiel JW. Choroidal myogenic autoregulation and intraocular pressure. Exp Eye Res. 1994;58:529-544.
3. Kiel JW, van Heuven WAJ. Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci. 1995;36:579-585.
4. Hardy P, Dumont I, Bhattacharya M, et al. Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. Cardiovasc Res. 2000;47:489-509.
5. Koss MC. Effects of inhibition of nitric oxide synthase on basal anterior segment ocular blood flows and on potential autoregulatory mechanisms. J Ocul Pharmacol Ther. 2001;17:319-329.
6. Riva CE, Titze P, Hero M, Petrig BL. Effect of acute decreases of perfusion pressure on choroidal blood flow in humans. Invest Ophthalmol Vis Sci. 1997;38:1752-1760.
7. Riva CE, Titze P, Hero M, Movaffaghy A, Petrig BL. Choroidal blood flow during isometric exercises. Invest Ophthalmol Vis Sci. 1997; 38:2338-2343.
8. Findl O, Strenn K, Wolzt M, et al. Effects of changes in intraocular pressure on human ocular haemodynamics. Curr Eye Res. 1997; 16:1024-1029.
9. Kiss B, Dallinger S, Polak K, Findl O, Eichler HG, Schmetterer L. Ocular hemodynamics during isometric exercise. Microvasc Res. 2001;61:1-13.
10. Hasler PW, Orgül S, Gulgleta K, et al. Vascular dysregulation in the choroid of subjects with acral vasospasm. Arch Ophthalmol. 2002; 120:302-307.
11. Bill A, Sperber GO. Control of retinal and choroidal blood flow. Eye 1990;4:319-325.
12. Rubanyi GM, Polokoff MA. Endothelia's molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325-415.
13. Polak K, Petternel V, Luksch A, et al. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects. Invest Ophthalmol Vis Sci. 2001;42:2949-2956.
14. Haefliger IO, Flammer J, Luscher TF. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci. 1992;33:2340-2343.
15. Meyer P, Flammer J, Luscher TF. Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest Ophthalmol Vis Sci. 1993;34:3614-3621.
16. Granstam E, Wang L, Bill A. Ocular effects of endothelin-1 in the cat. Curr Eye Res. 1992;11:325-332.
17. Granstam E, Wang L, Bill A. Vascular effects of endothelin-1 in the cat; modification by indomethacin and L-NAME. Acta Physiol Scand. 1993;148:165-176.
18. Kiel JW. Modulation of choroidal autoregulation in the rabbit. Exp Eye Res. 1999;69:413-429.
19. Kiel JW. Endothelin modulation of choroidal autoregulation in the rabbit. Exp Eye Res. 2000;71:543-550.
20. Nakagawa H. Effects of endothelin-1 on choroidal vessels. 2. Study using indocyanine green videoangiography [in Japanese]. Nippon Ganka Gakkai Zasshi. 2001;105:301-307.
21. Schmetterer L, Findl O, Strenn K, et al. Effects of endothelin-1 (ET-1) on ocular hemodynamics. Curr Eye Res. 1997;16:687-692.
22. Strenn K, Matulla B, Wolzt M, et al. Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans. Clin Pharmacol Ther. 1998;63:54-63.
23. Polska E, Doelemeyer A, Luksch A, et al. Topical unoprostone isopropyl partially antagonizes endothelin-1-induced vasoconstriction in the human choroid. Arch Ophthalmol. 2002;120:348-352.
24. Berg Nyborg NC, Nielsen PJ. Angiotensin II contracts isolated human posterior ciliary arteries. Invest Ophthalmol Vis Sci. 1990; 31:2471-2473.
25. Krejcy K, Wolzt M, Kreuzer C, et al. Characterisation of angiotensin-II effects on cerebral and ocular circulation by noninvasive methods. Br J Clin Pharmacol. 1997;43:501-508.
26. Matulla B, Streit G, Pieh S, et al. Effects of losartan on cerebral and ocular circulation in healthy subjects. Br J Clin Pharmacol. 1997; 44:369-375.
27. Geiser MH, Diermann U, Riva CE. Compact instrument for laser Doppler flowmetry in the foveal region of the choroid. Biomed Opt. 1999;4:459-464.
28. Geiser MH, Riva CE, Dorner GT, Diermann U, Luksch A, Schmetterer L. Response of choroidal blood flow in the foveal region to hyperoxia and hypercapnia. Curr Eye Res. 2000;21:669-676.
29. Ishikawa K, Fukami T, Nagase T, et al. Cyclic pentapeptide endothelin antagonists with high ETA selectivity: potency- and solubility-enhancing modifications. J Med Chem. 1992;35:2139-2142.
30. Berrazueta JR, Bhagat K, Vallance P, MacAllister RJ. Dose- and time-dependency of the dilator effects of the endothelin antagonist, BQ-123, in the human forearm. Br J Clin Pharmacol. 1997; 44:569-571.
31. Schmetterer L, Dallinger S, Bobr B, Selenko N, Eichler HG, Wolzt M. Systemic and renal effects of an ET(A) receptor subtype-specific antagonist in healthy subjects. Br J Pharmacol 1998;124:930-934.
32. Schmidt A, Bayerle-Eder M, Pleiner H, et al. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelinA receptor antagonist in men. Nitric Oxide. 2001;5:370-376.
33. Dallinger S, Dorner GT, Wenzel R, et al. Endothelin-1 contributes to hyperoxia-induced vasoconstriction in the human retina. Invest Ophthalmol Vis Sci. 2000;41:864-869.
34. Murphy JD, Vaughan RS, Rosen M. Intravenous enalaprilat and autonomic reflexes: the effects of enalaprilat on the cardiovascular responses to postural changes and tracheal intubation. Anaesthesia. 1989;44:816-821.
35. Robinson F, Riva CE, Riva JE, Petrig BL, Sinclair SH. Retinal blood flow autoregulation in response to an acute increase in blood pressure. Invest Opbtbalmol Vis Sci. 1986;27:722-726.
36. Riva CE, Cranstoun SD, Grunwald JE, Petrig BL. Choroidal blood flow in the foveal region of the human ocular fundus. Invest Ophthalmol Vis Sci. 1994;35:4273-4281.
37. Bonner R, Nossal R. Principles of laser-Doppler flowmetry. Dev Cardiovasc Med. 1990;107:17-45.
38. Marfella R, Gugliano D, di Maro G, Acampora R, Giunta R, D'Onofrio F. The squatting test: a useful tool to assess both parasympathetic and sympathetic involvement of the cardiovascular autonomic neuropathy in diabetes. Diabetes. 1994;43:607-612.
39. Haefliger IO, Dettmann E, Liu R, et al. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv Ophthalmol. 1999;43(suppl 1);S51-S58.
40. Pillunat LE, Stodtmeister R, Wilmanns I, Christ T. Autoregulation of ocular blood flow during changes in intraocular pressure: preliminary results. Graefes Arch Clin Exp Ophthalmol. 1985;223:219-223.
41. Quaranta L, Manni G, Donato F, Bucci MG. The effect of increased intraocular pressure on pulsatile ocular blood flow in low tension glaucoma. Surv Ophthalmol. 1994;38(suppl 1);S177-S181.
42. Evans DW, Harris A, Garrett M, Chung HS, Kagemann L. Glaucoma patients demonstrate faulty autoregulation of ocular blood flow during posture changes. Br J Ophthalmol. 1999;83:809-813.
43. Grunwald JE, Piltz J, Hariprasad SM, Dupont J, Maguire MG. Optic nerve blood flow in glaucoma: effect of systemic hypertension. Am J Ophthalmol. 1999;127:516-522.
44. Bursell SE, Clermont AC, Oren B, King GL. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats. Invest Ophthahnol Vis Sci. 1995;36:596-607.
45. Schmetterer L, Wolzt M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia. 1999;42:387-405.
46. Fuchsjäger-Mayrl G, Kautzky-Willer A, Kiss B, et al. Ocular hyperperfusion following onset of intensified insulin therapy is inversely correlated with plasma endothelin-1 in type 1 diabetes. Diabetologia. 2002;45:883-889.
47. Geier SA, Rolinski B, Sadri I, et al. Das okuläre Mikroangiopathie-Syndrom bei Patienten mit AIDS ist mit erhöhten Plasma-Spiegeln des Vasokonstriktors Endothelin-1 assoziiert. Klin Monatsbl Augenheilkd. 1995;207:353-360.